Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Agios Pharmaceuticals Stock Forecast NASDAQ:AGIO
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-17 | 56.47% | SVB Leerink | $30.00 $33.00 | Maintains | Market Perform |
| 2022-03-07 | 9.06% | Goldman Sachs | $37.00 $23.00 | Maintains | Sell |
| 2022-03-03 | 355.19% | HC Wainwright & Co. | $98.00 $96.00 | Maintains | Buy |
| 2022-02-25 | 217.69% | RBC Capital | $61.00 $67.00 | Maintains | Outperform |
| 2022-02-24 | 355.19% | HC Wainwright & Co. | $98.00 $96.00 | Maintains | Buy |
| 2022-02-22 | 42.25% | SVB Leerink | $32.00 $30.00 | Maintains | Market Perform |
| 2022-02-18 | 364.68% | HC Wainwright & Co. | $95.00 $98.00 | Maintains | Buy |
| 2022-02-16 | 108.63% | Canaccord Genuity | $52.00 $44.00 | Maintains | Buy |
| 2021-12-03 | 156.05% | B of A Securities | $54.00 | Initiates Coverage On | Buy |
| 2021-11-18 | 99.15% | SVB Leerink | $50.00 $42.00 | Maintains | Market Perform |
| 2021-11-04 | 350.45% | HC Wainwright & Co. | $93.00 $95.00 | Maintains | Buy |
| 2021-07-30 | 340.97% | HC Wainwright & Co. | $88.00 $93.00 | Maintains | Buy |
| 2021-07-30 | 84.92% | Goldman Sachs | $58.00 $39.00 | Downgrades | Neutral Sell |
| 2021-07-01 | - | Raymond James | - | Initiates Coverage On | Market Perform |
| 2021-06-10 | 317.26% | HC Wainwright & Co. | $88.00 | Initiates Coverage On | Buy |
| 2021-04-30 | 208.2% | Canaccord Genuity | $57.00 $65.00 | Maintains | Buy |
| 2021-03-01 | 156.05% | JP Morgan | $54.00 | Downgrades | Overweight Neutral |
| 2021-02-26 | 137.08% | SVB Leerink | $55.00 $50.00 | Downgrades | Outperform Market Perform |
| 2021-01-27 | 160.79% | SVB Leerink | $51.00 $55.00 | Maintains | Outperform |
| 2020-12-28 | 170.27% | Canaccord Genuity | $70.00 $57.00 | Maintains | Buy |
| 2020-12-09 | 189.24% | SVB Leerink | $67.00 $61.00 | Maintains | Outperform |
| 2020-10-22 | 118.11% | Barclays | $46.00 | Upgrades | Equal-Weight Overweight |
| 2020-10-19 | 231.91% | Canaccord Genuity | $72.00 $70.00 | Maintains | Buy |
| 2020-10-19 | 246.14% | Piper Sandler | $80.00 $73.00 | Maintains | Overweight |
| 2020-10-19 | 217.69% | SVB Leerink | $72.00 $67.00 | Maintains | Outperform |
| 2020-10-19 | 227.17% | Needham | $71.00 $69.00 | Maintains | Buy |
| 2020-07-31 | 241.39% | Cantor Fitzgerald | $70.00 $72.00 | Maintains | Overweight |
| 2020-06-15 | 241.39% | SVB Leerink | $70.00 $72.00 | Maintains | Outperform |
| 2020-06-15 | 255.62% | Citigroup | $64.00 $75.00 | Maintains | Buy |
| 2020-05-04 | 288.81% | JP Morgan | $72.00 $82.00 | Maintains | Overweight |
| 2020-03-04 | 137.08% | Barclays | $50.00 | Initiates Coverage On | Equal-Weight |
| 2020-02-14 | 231.91% | Cantor Fitzgerald | $64.00 $70.00 | Reiterates | Overweight |
| 2019-12-09 | 132.34% | BMO Capital | $45.00 $49.00 | Maintains | Outperform |
| 2019-12-04 | 222.43% | JP Morgan | $80.00 $68.00 | Maintains | Overweight |
| 2019-11-26 | 203.46% | Cantor Fitzgerald | $64.00 | Initiates Coverage On | Overweight |
| 2019-11-05 | 203.46% | Citigroup | $80.00 $64.00 | Maintains | Buy |
| 2019-09-23 | - | Guggenheim | - | Upgrades | Neutral Buy |
| 2019-09-12 | 113.37% | BMO Capital | $45.00 | Initiates Coverage On | Outperform |
| 2019-05-23 | 160.79% | Goldman Sachs | $55.00 | Assumes | Neutral |
AGIO Stock Trend
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.
Given the current short-term trend, the stock is expected to fall -31.43% during the next 3 months and, with a 90% probability hold a price between $12.71 and $17.16 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-25 | $18.35 | $21.60 | $24.84 |
| 2022-05-26 | $18.16 | $21.41 | $24.65 |
| 2022-05-27 | $17.98 | $21.22 | $24.46 |
| 2022-05-31 | $17.79 | $21.03 | $24.27 |
| 2022-06-01 | $17.60 | $20.84 | $24.09 |
| 2022-06-02 | $17.41 | $20.65 | $23.90 |
| 2022-06-03 | $17.22 | $20.47 | $23.71 |
| 2022-06-06 | $17.04 | $20.28 | $23.52 |
| 2022-06-07 | $16.85 | $20.09 | $23.33 |
| 2022-06-08 | $16.66 | $19.90 | $23.15 |
| 2022-06-09 | $16.47 | $19.71 | $22.96 |
| 2022-06-10 | $16.28 | $19.53 | $22.77 |
| 2022-06-13 | $16.10 | $19.34 | $22.58 |
| 2022-06-14 | $15.91 | $19.15 | $22.39 |
| 2022-06-15 | $15.72 | $18.96 | $22.21 |
| 2022-06-16 | $15.53 | $18.77 | $22.02 |
| 2022-06-17 | $15.34 | $18.59 | $21.83 |
| 2022-06-21 | $15.15 | $18.40 | $21.64 |
| 2022-06-22 | $14.97 | $18.21 | $21.45 |
| 2022-06-23 | $14.78 | $18.02 | $21.27 |
| 2022-06-24 | $14.59 | $17.83 | $21.08 |
| 2022-06-27 | $14.40 | $17.65 | $20.89 |
| 2022-06-28 | $14.21 | $17.46 | $20.70 |
| 2022-06-29 | $14.03 | $17.27 | $20.51 |
| 2022-06-30 | $13.84 | $17.08 | $20.33 |
| 2022-07-01 | $13.65 | $16.89 | $20.14 |
| 2022-07-05 | $13.46 | $16.71 | $19.95 |
| 2022-07-06 | $13.27 | $16.52 | $19.76 |
| 2022-07-07 | $13.09 | $16.33 | $19.57 |
| 2022-07-08 | $12.90 | $16.14 | $19.39 |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines for the treatment of cancer and rare genetic metabolic disorders in the United States. The companys product candidates include AG-221, an potent inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein that is in Phase I/II, Phase Ib combination, and Phase III IDHENTIFY clinical trials for the treatment of hematologic maligna... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
